11/07/2012 - 11:50am

The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.

11/06/2012 - 5:08pm

The Food and Drug Administration has approved a drug for rheumatoid arthritis ahead of the day the agency was scheduled to decide whether or not to approve it, the agency said Tuesday.

11/06/2012 - 12:46pm

Nutramax Laboratories recently announced the defeat of a class action lawsuit brought against the company in a California court. In April, Nutramax was named in a class action regarding its CosaminDS Joint Health Supplement. Plaintiffs claimed the glucosamine/chondroitin supplement did not work in relieving joint pain as advertised.

11/06/2012 - 12:23pm

Pennsylvania Gov. Tom Corbett last week signed into law S.B. 201, a bill that takes critical steps toward leveling the playing field between large pharmacy benefit managers and the mail-order pharmacies they own and local, independent community pharmacies.

11/05/2012 - 1:02pm

The ink was barely dry when we received this response to our Oct. 15, 2012, cover story, “Building the ACO.”


11/05/2012 - 11:11am

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.

11/02/2012 - 5:29pm

The Northeast is still recovering from one of the worst disasters it has ever faced. Many residents remain without electrical power, while others have lost their entire homes, businesses, workplaces and in a growing number of cases, their lives.

11/02/2012 - 9:39am

Rep. Edward Markey, D-Mass., on Thursday announced plans to introduce legislation that would strengthen federal regulations of compounding pharmacies.

11/02/2012 - 8:56am

The National Retail Federation and more than a dozen retailers on Thusday asked a judge to reject a proposed class-action settlement of a federal antitrust lawsuit filed against Visa and MasterCard because of credit card swipe fees.